Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Recruiting · NCT07723261 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | Not stated | 2026-07-24 | NCT07723261 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hellenic Cooperative Oncology Group | 12 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 2nd Oncology Department, Metropolitan Hospital | Athens | Greece | 1 |
| Attikon University General Hospital | Athens | Greece | 2 |
| General Hospital Agios Andreas | Pátrai | Greece | 1 |
| General Oncology Hospital Agioi Anargyroi | Athens | Greece | 1 |
| Hygeia Hospital | Athens | Greece | 5 |
| Ippokratio | Athens | Greece | 1 |
| Larissa University General Hospital | Larissa | Greece | 1 |
| Thessaloniki General Hospital "George Papanikolaou" | Thessaloniki | Greece | 1 |